These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2454100

  • 1. Mannose 6-phosphate/insulin like growth factor II receptor: the two types of ligands bind simultaneously to one receptor at different sites.
    Waheed A, Braulke T, Junghans U, von Figura K.
    Biochem Biophys Res Commun; 1988 May 16; 152(3):1248-54. PubMed ID: 2454100
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mannose 6-phosphate increases the affinity of its cation-independent receptor for insulin-like growth factor II by displacing inhibitory endogenous ligands.
    Polychronakos C, Guyda HJ, Posner BI.
    Biochem Biophys Res Commun; 1988 Dec 15; 157(2):632-8. PubMed ID: 2974283
    [Abstract] [Full Text] [Related]

  • 5. Effects of mannose-6-phosphate on receptor-mediated endocytosis of insulin-like growth factor-II.
    Polychronakos C, Guyda HJ, Janthly U, Posner BI.
    Endocrinology; 1990 Oct 15; 127(4):1861-6. PubMed ID: 2169404
    [Abstract] [Full Text] [Related]

  • 6. Endocytosis of receptor-bound insulin-like growth factor II is enhanced by mannose-6-phosphate in IM9 cells.
    Polychronakos C, Piscina R.
    Endocrinology; 1988 Dec 15; 123(6):2943-5. PubMed ID: 2973978
    [Abstract] [Full Text] [Related]

  • 7. Endocytosis of receptor-bound insulin-like growth factor II is enhanced by mannose-6-phosphate in IM9 cells.
    Polychronakos C, Piscina R.
    Endocrinology; 1988 Oct 15; 123(4):2146-8. PubMed ID: 2970962
    [Abstract] [Full Text] [Related]

  • 8. Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor.
    Kiess W, Blickenstaff GD, Sklar MM, Thomas CL, Nissley SP, Sahagian GG.
    J Biol Chem; 1988 Jul 05; 263(19):9339-44. PubMed ID: 2967821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of osteoblast insulin-like growth factor-II/cation-independent mannose-6-phosphate receptors by specific phosphorylated sugars and antibodies induce insulin-like growth factor-II effects.
    Ishibe M, Rosier RN, Puzas JE.
    Endocr Res; 1991 Jul 05; 17(3-4):357-66. PubMed ID: 1667383
    [Abstract] [Full Text] [Related]

  • 11. Structure of the receptor for insulin-like growth factor II: the puzzle amplified.
    Roth RA.
    Science; 1988 Mar 11; 239(4845):1269-71. PubMed ID: 2964085
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification and in situ localization of the insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptor in the rat gastrointestinal tract: comparison with the IGF-I receptor.
    Heinz-Erian P, Kessler U, Funk B, Gais P, Kiess W.
    Endocrinology; 1991 Oct 11; 129(4):1769-78. PubMed ID: 1655382
    [Abstract] [Full Text] [Related]

  • 14. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR, De Souza AT, Byrd JC, Jirtle RL, MacDonald RG.
    Cancer Res; 1999 Sep 01; 59(17):4314-9. PubMed ID: 10485478
    [Abstract] [Full Text] [Related]

  • 15. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
    Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F.
    Mol Endocrinol; 1990 Sep 01; 4(9):1327-35. PubMed ID: 2172799
    [Abstract] [Full Text] [Related]

  • 16. Chronic ethanol administration decreases the ligand binding properties and the cellular content of the mannose 6-phosphate/insulin-like growth factor II receptor in rat hepatocytes.
    Haorah J, McVicker DL, Byrd JC, MacDonald RG, Donohue TM.
    Biochem Pharmacol; 2002 Apr 01; 63(7):1229-39. PubMed ID: 11960599
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
    Zavorka ME, Connelly CM, Grosely R, MacDonald RG.
    Oncotarget; 2016 Sep 20; 7(38):62386-62410. PubMed ID: 27694692
    [Abstract] [Full Text] [Related]

  • 18. The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II.
    Tong PY, Tollefsen SE, Kornfeld S.
    J Biol Chem; 1988 Feb 25; 263(6):2585-8. PubMed ID: 2963812
    [Abstract] [Full Text] [Related]

  • 19. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of the insulin-like growth factor II binding site to domains 5-11.
    Dahms NM, Wick DA, Brzycki-Wessell MA.
    J Biol Chem; 1994 Feb 04; 269(5):3802-9. PubMed ID: 8106425
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-II/mannose 6-phosphate receptor is incapable of activating GTP-binding proteins in response to mannose 6-phosphate, but capable in response to insulin-like growth factor-II.
    Okamoto T, Nishimoto I, Murayama Y, Ohkuni Y, Ogata E.
    Biochem Biophys Res Commun; 1990 May 16; 168(3):1201-10. PubMed ID: 2161218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.